ORA and CDER agree to replace and/or withdraw CPGs in favor of using guidance or procedural documents, as appropriate per GGP regulations.
Similar Posts
X3 500K GOLD EDITION may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use X3 500K GOLD EDITION, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.CDER SBIA Chronicles
FDA/CDER SBIA Chronicles, the bi-monthly newsletter of the CDER Small Business and Industry Assistance team, provides industry with useful information to assist in all aspects of drug marketing and regulationPatient Listening Session Summaries
Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Public Engagement Staff draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.IF Copack LLC dba Initiative Foods Recalls “Tippy Toes” Brand Apple Pear Banana Because of Possible Health Risk
Sanger, CA – February 13, 2026 – IF Copack LLC d.b.a. Initiative Foods (“Initiative Foods”) is recalling one lot of the “Tippy Toes” brand Apple Pear Banana Fruit puree (“Product”) due to elevated levels of patulin. Patulin is a naturally occurring substance (called a mycotoxin) which is produced bEstaderma – 718714 – 11/03/2025
Unapproved New Drugs/Misbranded BotoxCDER Guidance Agenda
CDER Guidance Agenda
